Atrovent HFA

Atrovent HFA is a brand name of ipratropium, approved by the FDA in the following formulation(s):

ATROVENT HFA (ipratropium bromide - aerosol, metered; inhalation)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: November 27, 2004
  
  Strength(s): 0.021MG/INH ^[RLD]

Has a generic version of Atrovent HFA been approved?

No. There is currently no therapeutically equivalent version of Atrovent HFA available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Atrovent HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Stabilized medicinal aerosol solution formulations
  Patent 5,676,930
  Issued: October 14, 1997
  Inventor(s): Jager; Paul Donald & Kontny; Mark James & Nagel; Jurgen Hubert
  Assignee(s): Boehringer Ingelheim Pharmaceuticals, Inc.
  Stabilized medicinal aerosol solution formulations comprising medicaments that degrade or decompose by interaction with solvents or water, an HFC propellant, a cosolvent and an acid are described. Further, specific medicinal aerosol solution formulations comprising ipratropium bromide or fenoterol, ethyl alcohol, 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane, and either an inorganic acid or an organic acid are described. The acids are present in amounts sufficient to reduce the degradation of the medicaments to acceptable levels.
  
  Patent expiration dates:
  
  
  • October 14, 2014
    
    ✓ 
    Drug product
  
  



• 
  Medicinal aerosol formulations
  Patent 5,683,677
  Issued: November 4, 1997
  Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
  Assignee(s): Riker Laboratories, Inc.
  A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
  
  Patent expiration dates:
  
  
  • November 4, 2014
    
    ✓ 
    Drug product
  
  



• 
  Stainless steel canister for propellant-driven metering aerosols
  Patent 6,739,333
  Issued: May 25, 2004
  Inventor(s): Hubert; Hoelz & Richard Thomas; Lostritto & Juergen; Nagel & Julio César; Vega
  Assignee(s): Boehringer Ingelheim Pharma KG
  The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol forumlations for use in propellant gas-operated inhalers.
  
  Patent expiration dates:
  
  
  • May 26, 2020
    
    ✓ 
    Drug product
  
  



• 
  Stainless steel canister for propellant-driven metering aerosols
  Patent 6,983,743
  Issued: January 10, 2006
  Inventor(s): Hoelz; Hubert & Lostritto; Richard Thomas & Nagel; Juergen & Vega; Julio César
  Assignee(s): Boehringer Ingelheim Pharma KG
  The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol formulations for use in propellant gas-operated inhalers.
  
  Patent expiration dates:
  
  
  • May 26, 2020
    
    ✓ 
    Drug product
  
  

See also...

• Atrovent HFA Aerosol Suspension Consumer Information (Wolters Kluwer)
• Atrovent HFA Consumer Information (Cerner Multum)
• Ipratropium Aerosol Suspension Consumer Information (Wolters Kluwer)
• Ipratropium Solution Consumer Information (Wolters Kluwer)
• Ipratropium inhalation Consumer Information (Cerner Multum)
• Alti-Ipratropium Advanced Consumer Information (Micromedex)
• Alti-Ipratropium With Preservative Advanced Consumer Information (Micromedex)
• Apo-Ipravent Advanced Consumer Information (Micromedex)
• Ipratropium Bromide Nebuamp Advanced Consumer Information (Micromedex)
• Ipratrovent Sterules Advanced Consumer Information (Micromedex)
• Ratio-Ipratropium Advanced Consumer Information (Micromedex)
• Ratio-Ipratropium Udv Advanced Consumer Information (Micromedex)
• Ipratropium Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Ipratropium Bromide AHFS DI Monographs (ASHP)